RecruitingNot ApplicableNCT03371641

In Utero Alcoholic Exposure: PlGF, Biomarker of Fetal Brain Lesions

Sponsor

University Hospital, Rouen

Enrollment

60 participants

Start Date

Jan 27, 2017

Study Type

INTERVENTIONAL

Conditions

Fetal Alcohol Syndrome

Summary

This study aims to validate that PLGF is a biomarker of cerebral lesions and therefore of secondary developmental disorders and disabilities that will be best diagnosed at 2 and 6 years of age.

Eligibility

Sex: FEMALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a behavioral approach called ASQ parental questionnaire, a procedure called Blood sample (mother), and others for people with fetal alcohol syndrome. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALASQ parental questionnaire

ASQ parental questionnaire

BEHAVIORALDevelopment scales

WPPSI - IV and NEPSY development scales

BEHAVIORALScale of Conners

Scale of Conners

BEHAVIORALSCQ Questionnaire

SCQ questionnaire

PROCEDUREBlood sample (mother)

Blood sample (mother) before delivery

PROCEDURECord blood sample

Cord blood sample after delivery

PROCEDUREPlacenta sample

Placenta sample

Locations(1)

UH ROUEN

Rouen, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03371641

Related Trials

RCT of Prenatal Choline Supplementation During Pregnancy to Mitigate Adverse Effects of Prenatal Alcohol Exposure

NCT043951961 location

The Oklahoma Parent-Child Assistance Program

NCT055345682 locations